Science at Sanofi

Explore latest events, medical insights and trends.

Events

Stay up to date and register for the latest events and view webinar recordings

See everything

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

Read article

Asia Pompe Expert Forum Highlights Rewind

Read article

The Importance of Flu Vaccination and Effective Communication

Read article

AAD 2025

March 7–11, 2025; Orlando, Florida, USA

Read article

ACC Congress 2025

Read article

ATTD 2025 Congress Updates

Read article

EASD 2024 Congress Updates

Read article

ESC 2024 Congress Highlights

Read article

See everything

Cutting-Edge Science

Discover medical insights and trends from trusted sources and key opinion leaders.

See everything

Personalizing Cardiovascular Care in Asian Populations: Insights on Antiplatelet Safety & Lipid Risk

Read article

Beyfortus<sup>®</sup>: Made with All Infants in Mind to Protect Against RSV

Beyfortus^{^®}: Made with All Infants in Mind to Protect Against RSV

Up to 75% of RSV-associated hospitalisations occur in healthy and full-term children.² Recent studies have shown that nirsevimab provided up to 90% protection against hospitalisation from severe RSV LRTI in infants during their first RSV season.³

Read article

Understanding RSV: Disease Burden and Nirsevimab’s Efficacy

In Singapore, RSV circulates all-year round and causes significant paediatric health and economic burden.² This highlights the need and importance of RSV immunisation to reduce the burden of disease.²

Read article